CHINA NATIONAL BIOTEC GROUP

Omicron-specific Sinopharm, Sinovac Covid vaccine candidates cleared for clinical trial

The two candidates from units of Sinopharm subsidiary China National Biotec Group (CNBG) and one from Sinovac contain inactivated or "killed" coronavirus and are similar to vaccines that the companies are supplying in China and overseas, the companies said in statements.